Trends in Guideline-Driven Revascularization in Diabetic Patients with Multivessel Coronary Heart Disease

Umme Rumana1,2, Richard Kones2, Montather O Taheer3

  • 1The University of Texas Health Science Center at Houston (UTHealth) School of Biomedical Informatics, Houston, TX 77030, USA.

Insights

Coronary artery bypass grafting (CABG) remains recommended for diabetes patients with 3-vessel disease. A study found no significant change in the odds of receiving CABG versus percutaneous coronary intervention (PCI) after 2011 guidelines. This suggests modern practice considers patient choice and other factors in revascularization decisions.

Area of Science:

  • Cardiology
  • Health Services Research

Background:

  • Coronary artery bypass grafting (CABG) has a class I recommendation for diabetes patients with chronic ≥3 vessel disease per 2011 ACC/AHA guidelines.
  • Existing literature primarily compares outcomes of CABG versus percutaneous coronary intervention (PCI), with limited data on procedure selection odds.

Purpose of the Study:

  • To compare the odds of receiving CABG versus PCI in diabetes patients with chronic ≥3 vessel disease before and after the 2011 ACC/AHA guidelines.
  • To identify factors influencing the choice between CABG and PCI in this high-risk patient population.

Main Methods:

  • A secondary analysis of a de-identified database of 30,482 patients was conducted.
  • Odds of CABG versus PCI were determined as the binary dependent variable in two periods: pre-guidelines (2009-2011) and post-guidelines (2013-2015).
  • Logistic regression controlled for gender, ethnicity/race, and ischemic heart disease.

Main Results:

  • The odds of CABG versus PCI in the post-guideline period were not statistically significantly different from the pre-guideline period (odds ratio = 0.98, 95% CI = 0.925-1.032, p=0.400).
  • Ethnicity/race, gender, and heart disease significantly contributed to the prediction model (p < 0.05).
  • No significant rise in CABG odds was observed in high-risk patients with diabetes and multivessel coronary heart disease post-guidelines.

Conclusions:

  • Despite guidelines, the odds of undergoing CABG versus PCI did not significantly change among high-risk diabetes patients with multivessel disease.
  • Modern revascularization decisions likely involve patient choice and additional variables beyond guideline recommendations.
  • The reliability of procedure occurrence odds as a surrogate for provider guideline compliance remains uncertain.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
198
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
551
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.7K
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
289
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
300
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
285